Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanxi Yuning Biotechnology is a high-tech enterprise based in Taiyuan, China, that specializes in the research, development, and large-scale production of biological enzymes and coenzyme factors. The company is a leading supplier of β-Nicotinamide Mononucleotide (NMN), Nicotinamide Adenine Dinucleotide (NAD), and other related nucleotides used in the health supplement and pharmaceutical industries. Utilizing a proprietary biocatalysis platform, Shanxi Yuning employs green chemistry and enzymatic synthesis to produce high-purity ingredients more sustainably than traditional chemical methods. Their facilities are designed to meet international quality standards, catering to a global market focused on anti-aging and metabolic wellness. The company's core expertise lies in enzyme engineering and directed evolution, which enables the efficient synthesis of complex biological molecules.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shanxi YuNing Biotechnology.